Virus News and Research

RSS

A virus is a microscopic infectious agent that can reproduce only inside a host cell. Viruses infect all types of organisms: from animals and plants, to bacteria and archaea. Since the initial discovery of tobacco mosaic virus by Martinus Beijerinck in 1898, more than 5,000 types of virus have been described in detail, although most types of virus remain undiscovered. Viruses are ubiquitous, as they are found in almost every ecosystem on Earth, and are the most abundant type of biological entity on the planet. The study of viruses is known as virology, and is a branch of microbiology.

Announcing the Winners of The Scientist’s Top 10 Innovations of 2021

Each year The Scientist seeks to highlight the latest and greatest tools, technologies, and techniques to hit the life science landscape.

From Resolve Biosciences 6 Dec 2021

New nanoparticle adjuvant could lead to more powerful vaccines

A common strategy to make vaccines more powerful is to deliver them along with an adjuvant -; a compound that stimulates the immune system to produce a stronger response.

6 Dec 2021

Nanoparticles mimicking flu viruses to deliver large biological drug molecules

Nanoengineers from the University of California San Diego recently created a new and potentially efficient means to deliver messenger RNA (mRNA) into cells.

2 Dec 2021

Experts create new software that determines a person’s past infections

Recent research suggested that grouping of pathogen-recognizing proteins on immune T cells might be vital in pinpointing if an individual had an infection in the past.

2 Dec 2021

Cytomegalovirus accelerates the decline of the immune system regardless of age

Scientists from the University of Córdoba have been investigating the changes that occur in the T lymphocytes of the immune system with increasing age.

2 Dec 2021

New CRISPR technology could improve diagnostic tests for COVID-19

A new type of CRISPR platform that leverages the benefits of a compact RNA-editing protein could result in enhanced diagnostic tests for COVID-19.

2 Dec 2021

Study analyzes response of individuals from diverse populations to infections

A recent study has identified differences in immune pathway activation to influenza infection between people of European and African genetic ancestry.

2 Dec 2021

Custom Biofluid & Tissue Procurement Service

Global provider of human and animal biospecimens - AMSBIO offers a custom procurement service enabling researchers to source specific biofluid and tissue samples which are not already available in their extensive biorepository.

From AMS Biotechnology 1 Dec 2021

Plant-based antiviral treatment found to be effective at treating all SARS-CoV-2 variants

A plant-based antiviral treatment for Covid-19, recently discovered by scientists at the University of Nottingham, has been found to be just as effective at treating all variants of the virus SARS-CoV-2, even the highly infectious Delta variant.

29 Nov 2021

Anti-idiotype antibodies may explain the long-term effects of COVID-19

With around 256 million cases and more than 5 million deaths worldwide, the COVID-19 pandemic has challenged scientists and those in the medical field. Researchers are working to find effective vaccines and therapies, as well as understand the long-term effects of the infection.

From The University of California, Davis 26 Nov 2021

Study analyzes connections between COVID-19 severity and gene expression

Recent research reveals how genetic variations associated with severe cases of COVID-19 impact the immune cells.

25 Nov 2021

Viral RNA undergoes conformational changes to hijack host cells, says study

Scientists from the University of Colorado Anschutz Medical Campus recently identified how an RNA molecule from a virus develops a complex, three-dimensional structure, and is capable of changing its shape to hijack host proteins.

25 Nov 2021

Research could help understand DCIR's role in the pathogenesis of autoimmune diseases

While dendritic cell immunoreceptor (DCIR) is known to mediate inflammation and bone metabolism, ligands that bind DCIR and the mechanisms underlying DCIR activity remain poorly understood.

From Tokyo University of Science 25 Nov 2021

Covid-19 vaccine-elicited immune cells persist six months after vaccination, study shows

A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes — immune system cells also known as helper T cells — produced by people who received either of the two available messenger RNA (mRNA) vaccines for COVID-19 persist six months after vaccination at only slightly reduced levels from two weeks after vaccination and are at significantly higher levels than for those who are unvaccinated.

17 Nov 2021

Virus News and Research

Announcing the Winners of The Scientist’s Top 10 Innovations of 2021

New nanoparticle adjuvant could lead to more powerful vaccines

Nanoparticles mimicking flu viruses to deliver large biological drug molecules

Experts create new software that determines a person’s past infections

Cytomegalovirus accelerates the decline of the immune system regardless of age

New CRISPR technology could improve diagnostic tests for COVID-19

Study analyzes response of individuals from diverse populations to infections

Custom Biofluid & Tissue Procurement Service

Plant-based antiviral treatment found to be effective at treating all SARS-CoV-2 variants

Anti-idiotype antibodies may explain the long-term effects of COVID-19

Study analyzes connections between COVID-19 severity and gene expression

Viral RNA undergoes conformational changes to hijack host cells, says study

Research could help understand DCIR's role in the pathogenesis of autoimmune diseases

Covid-19 vaccine-elicited immune cells persist six months after vaccination, study shows

Study identifies new gene that promotes progression to type 1 diabetes

Research details how HIV-infected cells evade detection by the immune system

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

Avoiding the formation of false positive results during SARS-CoV-2 antigen testing

Study explores mechanism by which ToBRFV tomato virus overcomes tobamovirus resistance

Study identifies a compound capable of easing symptoms of coronavirus infections

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics